PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels

Endocrinology

Volumn 152, Issue 11, 2011, Pages 4053-4061

  Yuan, Quan ^a,b   Sitara, Despina ^a   Sato, Tadatoshi ^a   Densmore, Michael ^a   Saito, Hiroaki ^a   Schul̈er, Christine ^c   Erben, Reinhold G ^c   Lanske, Beate ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; GENE DELETION; GENETIC MODEL; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PARATHYROID HORMONE BLOOD LEVEL; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; SOFT TISSUE; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL;

ANIMALS; BONE AND BONES; CALCIUM; FIBROBLAST GROWTH FACTORS; INFUSION PUMPS; MICE; MICE, KNOCKOUT; PARATHYROID HORMONE; VITAMIN D;

EID: 80054930335     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1113     Document Type: Article

References (35)

1. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
2. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421-432 (Pubitemid 39576657)
3. Bergwitz C, Jüppner H 2010 Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91-104
4. ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR Consortium. Nat Genet 26:345-348
5. Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, Erben RG, Lanske B 2006 Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161-2170 (Pubitemid 351181975)
6. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N 2007 Mineralized tissue cells are a principal source of FGF23. Bone 40:1565-1573 (Pubitemid 46756409)
7. Mirams M, Robinson BG, Mason RS, Nelson AE 2004 Bone as a source of FGF23: regulation by phosphate? Bone 35:1192-1199 (Pubitemid 39487366)
8. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M 2006 Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem 281:6120-6123 (Pubitemid 43847540)
9. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774 (Pubitemid 44949607)
10. Tomiyama K, Maeda R, Urakawa I, Yamazaki Y, Tanaka T, Ito S, Nabeshima Y, Tomita T, Odori S, Hosoda K, Nakao K, Imura A, Nabeshima Y 2010 Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci USA 107:1666-1671
11. Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS 2009 In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J 23:433-441
12. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J 2007 The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003-4008 (Pubitemid 350224109)
13. Krajisnik T, Bjö rklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE 2007 Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125-131
14. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435 (Pubitemid 38787398)
15. Razzaque MS, Sitara D, Taguchi T, St. Arnaud R, Lanske B 2006 Premature ageing-like phenotype in fibroblast growth factor 23 null mice is a vitamin-D mediated process. FASEB J 20:720-722 (Pubitemid 46671193)
16. Hesse M, Frö hlich LF, Zeitz U, Lanske B, Erben RG 2007 Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26:75-84
17. Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B 2008 FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 182:459-465
18. Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H, Suda T, DeLuca HF 1998 Parathyroid hormone activation of the 25-hydroxyvitamin D3-1α-hydroxylase gene promoter. Proc Natl Acad Sci USA 95:1387-1391
19. Murayama A, Takeyama K, Kitanaka S, Kodera Y, Hosoya T, Kato S 1998 The promoter of the human 25-hydroxyvitamin D3 1α-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1α,25(OH)2D3. Biochem Biophys Res Commun 249:11-16 (Pubitemid 28418685)
20. Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schüler C, Erben RG, Lanske B 2008 Genetic evidence of serum phosphateindependent functions of FGF-23 on bone. PLoS Genet 4:e1000154
21. Cantley LK, Russell J, Lettieri D, Sherwood LM 1985 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117:2114-2119 (Pubitemid 16194269)
22. Chan YL, McKay C, Dye E, Slatopolsky E 1986 The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif Tissue Int 38:27-32 (Pubitemid 16187010)
23. McLeod MJ 1980 Differential staining of cartilage and bone in whole fetuses by alcian blue and alizarin red S. Teratology 22:299-301 (Pubitemid 11209786)
24. Yuan Q, Sato T, Densmore M, Saito H, Schuler C, Erben RG, Lanske B 2011 Fgf23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res 26:2026-2035
25. DeLuca S, Sitara D, Kang K, Marsell R, Jonsson K, Taguchi T, Erben RG, Razzaque MS, Lanske B 2008 Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J Pathol 216:345-355
26. Ohnishi M, Nakatani T, Lanske B, Razzaque MS 2009 Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase. Kidney Int 75:1166-1172
27. Stubbs JR, Liu S, Tang W, Zhou J, Wang Y, Yao X, Quarles LD 2007 Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18:2116-2124 (Pubitemid 47041077)
28. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y 2003 Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17:2393-2403 (Pubitemid 37542205)
29. Morishita K, Shirai A, Kubota M, Katakura Y, Nabeshima Y, Takeshige K, Kamiya T 2001 The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 131:3182-3188 (Pubitemid 33136132)
30. Segawa H, Onitsuka A, Furutani J, Kaneko I, Aranami F, Matsumoto N, Tomoe Y, Kuwahata M, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K 2009 Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am J Physiol Renal Physiol 297:F671-F678
31. Ohnishi M, Nakatani T, Lanske B, Razzaque MS 2009 In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels. Circ Cardiovasc Genet 2:583-590
32. Ohnishi M, Razzaque MS 2010 Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24:3562-3571
33. Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23:939-948 (Pubitemid 351768812)
34. Liu S, Guo R, Tu Q, Quarles LD 2002 Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277:3686-3697 (Pubitemid 34953243)
35. Bai X, Miao D, Panda D, Grady S, McKee MD, Goltzman D, Karaplis AC 2002 Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol 16:2913-2925 (Pubitemid 36020666)